Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository — Stella

Home/Vaginitis/

View on ClinicalTrials.gov

Recruiting

Back to Vaginitis trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Peking University Shenzhen Hosptal, Shenzhen, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Peking University Shenzhen Hospital

Enrollment target

~50 participants

Started

May 2020

Primary completion

December 2026

Age range

18 Years – 55 Years

Sex

Female only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.